bell
The current prices are delayed by 15 mins, login to check live prices.
Lyka Labs Ltd share price logo

Lyka Labs Ltd

(LYKALABS)

₹164.610.33%

as on 04:01PM, 06 Sep 2024

Overview
News
Financials
Q1 2024 Results
Technicals

Performance

  • Day's Low

    Day's High

    ₹159.3
    ₹172.5
  • 52 Week's Low

    52 Week's High

    ₹97.9
    ₹172.5
1 Month Return+ 45 %
3 Month Return+ 54.2 %
1 Year Return+ 41.58 %
Previous Close₹165.15
Open₹166.80
Volume10.43L
Upper Circuit-
Lower Circuit-
Market Cap₹589.42Cr

Key Statistics

P/E Ratio-54.15
PEG Ratio-23.04
Market Cap₹589.42 Cr
P/B Ratio3.88
EPS-0.79
Dividend Yield0
SectorPharmaceuticals
ROE0

Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹589.42 Cr182.64%0.69-₹3 Cr₹111 Cr
BUY₹28,124.56 Cr20.69%0.52NANA
NA₹327.69 Cr83.66%0.52NANA
NA₹16.34 Cr143.14%0.69NANA
NA₹478.43 Cr339.6%0.54₹21 Cr₹144 Cr

Company Information

Lyka Labs, a bulk drug company, has been in the business of offering lifesaving antibiotics and treating minor infections for over three decades. Over the years, the company has also diversified into marketing medical and diagnostic machinery and equipment, ayurvedic and animal health care products, tropical steroids, anticancer products, cardiovascular drugs, and anti-inflammatory products. In the year 1991 they received a Certificate of Merit for their impressive export performance and an award from CHEMEXCIL. Two years later, their Administrative Office and Plant at Tarapur was awarded the ISO 9002 certification for its quality management system. As part of its diversification, the company had also invested in Relic Finance and acquired 26.70% of the company's paid-up equity capital through a public offer. They also launched India's first Glutathione Injection formulation during 2012-13 to become one of India's leading healthcare and pharmaceutical companies.

Share Price: ₹164.61 per share as on 06 Sep, 2024 04:01 PM
Market Capitalisation: ₹589.42Cr as of today
Revenue: ₹30.11Cr as on June 2024 (Q2 24)
Net Profit: ₹1.44Cr as on June 2024 (Q2 24)
Listing date: 09 Feb, 1995
Chairperson Name: KUNAL NARENDRA GANDHI
OrganisationLyka Labs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Lyka Labs Ltd

  • Lyka Labs Reports 38.7% YoY Increase in Net Sales - 22 May, 2024

    Lyka Labs reports a 38.7% YoY increase in net sales for March 2024, with quarterly net loss at Rs. 1.62 crore, up 46.06% from the previous year. EBITDA stands at Rs. 2.60 crore, down 22.16% YoY. The stock has given -10.47% returns over the last 6 months and 17.26% over the last 12 months.

Insights on Lyka Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 40.92% to 40.99% in Jun 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LYKALABS stock has moved up by 8.4%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 28.08 Cr → 30.67 Cr (in ₹), with an average increase of 8.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -2.13 Cr → 1.44 Cr (in ₹), with an average increase of 247.9% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 58.10% of holdings in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 79.1% return, outperforming this stock by 37.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 132.9% return, outperforming this stock by 5.9%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.16% to 0.15% in Jun 2024 quarter

Company Financials

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹22.88Cr (-)₹27.99Cr (↑22.33%)₹32.56Cr (↑16.33%)₹27.77Cr (↓14.71%)₹30.11Cr (↑8.43%)
Net Income-₹1.85Cr (-)-₹0.49Cr (↓73.51%)₹1.78Cr (↓463.27%)-₹2.13Cr (↓219.66%)₹1.44Cr (↓167.61%)
Net Profit Margin-8.09% (-)-1.75% (↓78.37%)5.47% (↓412.57%)-7.67% (↓240.22%)4.78% (↓162.32%)
Value in ₹ crore
Details2021202220232024
Total Assets₹213.37Cr (-)₹208.51Cr (↓2.28%)₹178.86Cr (↓14.22%)₹185.89Cr (↑3.93%)
Total Liabilities₹208.25Cr (-)₹163.29Cr (↓21.59%)₹101.35Cr (↓37.93%)₹85.48Cr (↓15.66%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹11.45Cr (-)₹5.75Cr (↓150.22%)₹76.53Cr (↑1,230.96%)₹6.87Cr (↓91.02%)₹3.09Cr (↓55.02%)
0

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
58.1%
0.00
Foreign Institutions
0.15%
-0.90
Mutual Funds
0.01%
0.00
Retail Investors
40.99%
0.17
Others
0.74%
-8.63

Key Indicators

Details20202021202220232024
Earning Per Share (₹)-21.83-3.5213.4-4.29-0.79
Details2022
Return On Equity %58.27
Details20202021202220232024
Return On Assets %-27.36-5.4118.7-7.39-1.34
Details20202021202220232024
Book Value Per Share (₹)-5-8.994.659.1217.86

Lyka Labs Ltd Valuation

Lyka Labs Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-164.66x)

September 10, 2018

Today (-54.15x)

September 5, 2024

Industry (58.97x)

September 5, 2024

Highest (23.04x)

September 5, 2022

LowHigh

Earnings and Dividends

  • Lyka Labs Ltd Earnings Results

    Lyka Labs Ltd’s net profit jumped 177.84% since last year same period to ₹1.44Cr in the Q1 2024-2025. On a quarterly growth basis, Lyka Labs Ltd has generated 167.61% jump in its net profits since last 3-months.

    Read More about Earnings Results

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Lyka Labs Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Lyka Labs Ltd shares.

Lyka Labs Ltd (LYKALABS) share price today is ₹164.61

Lyka Labs Ltd is listed on NSE

Lyka Labs Ltd is listed on BSE

  • Today’s highest price of Lyka Labs Ltd is ₹172.5.
  • Today’s lowest price of Lyka Labs Ltd is ₹159.3.

PE Ratio of Lyka Labs Ltd is -54.15

PE ratio = Lyka Labs Ltd Market price per share / Lyka Labs Ltd Earnings per share

Today’s traded volume of Lyka Labs Ltd(LYKALABS) is 10.43L.

Today’s market capitalisation of Lyka Labs Ltd(LYKALABS) is ₹589.42Cr.

Lyka Labs Ltd(LYKALABSPrice
52 Week High
₹172.5
52 Week Low
₹97.9

Lyka Labs Ltd(LYKALABS) share price is ₹164.61. It is down -4.57% from its 52 Week High price of ₹172.5

Lyka Labs Ltd(LYKALABS) share price is ₹164.61. It is up 68.14% from its 52 Week Low price of ₹97.9

Lyka Labs Ltd(LYKALABSReturns
1 Day Returns
-0.54%
1 Month Returns
45%
3 Month Returns
54.2%
1 Year Returns
41.58%